Principal Securities’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.87K Sell
59
-12
-17% -$584 ﹤0.01% 3032
2025
Q1
$2.8K Hold
71
﹤0.01% 2948
2024
Q4
$2.8K Sell
71
-576
-89% -$22.7K ﹤0.01% 2943
2024
Q3
$30.4K Buy
647
+7
+1% +$329 ﹤0.01% 1916
2024
Q2
$34.6K Sell
640
-706
-52% -$38.1K ﹤0.01% 1793
2024
Q1
$91.7K Buy
1,346
+695
+107% +$47.4K ﹤0.01% 1309
2023
Q4
$40.8K Buy
+651
New +$40.8K ﹤0.01% 1579